These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
30. Skeletal muscle expression of adipose-specific phospholipase in peripheral artery disease. Parmer C; De Sousa-Coelho AL; Cheng HS; Daher G; Burkart A; Dreyfuss JM; Pan H; Prenner JC; Keilson JM; Pande R; Henkin S; Feinberg MW; Patti ME; Creager MA Vasc Med; 2020 Oct; 25(5):401-410. PubMed ID: 32853041 [TBL] [Abstract][Full Text] [Related]
31. Association of monocyte tumor necrosis factor α expression and serum inflammatory biomarkers with walking impairment in peripheral artery disease. Pande RL; Brown J; Buck S; Redline W; Doyle J; Plutzky J; Creager MA J Vasc Surg; 2015 Jan; 61(1):155-61. PubMed ID: 25095746 [TBL] [Abstract][Full Text] [Related]
32. Walking performance is positively correlated to calf muscle fiber size in peripheral artery disease subjects, but fibers show aberrant mitophagy: an observational study. White SH; McDermott MM; Sufit RL; Kosmac K; Bugg AW; Gonzalez-Freire M; Ferrucci L; Tian L; Zhao L; Gao Y; Kibbe MR; Criqui MH; Leeuwenburgh C; Peterson CA J Transl Med; 2016 Sep; 14(1):284. PubMed ID: 27687713 [TBL] [Abstract][Full Text] [Related]
33. Skeletal muscle mitochondrial ATP production rate and walking performance in peripheral arterial disease. Hou XY; Green S; Askew CD; Barker G; Green A; Walker PJ Clin Physiol Funct Imaging; 2002 May; 22(3):226-32. PubMed ID: 12076351 [TBL] [Abstract][Full Text] [Related]
34. Effects of exercise training with weight loss on skeletal muscle expression of angiogenic factors in overweight and obese older men. Evans WS; Blumenthal JB; Heilman JM; Ryan AS; Prior SJ J Appl Physiol (1985); 2021 Jul; 131(1):56-63. PubMed ID: 34013746 [TBL] [Abstract][Full Text] [Related]
35. Effects of oral N-acetylcysteine on walking capacity, leg reactive hyperemia, and inflammatory and angiogenic mediators in patients with intermittent claudication. da Silva ND; Roseguini BT; Chehuen M; Fernandes T; Mota GF; Martin PK; Han SW; Forjaz CL; Wolosker N; de Oliveira EM Am J Physiol Heart Circ Physiol; 2015 Sep; 309(5):H897-905. PubMed ID: 26116711 [TBL] [Abstract][Full Text] [Related]
36. Effect of training on the response of plasma vascular endothelial growth factor to exercise in patients with peripheral arterial disease. Wood RE; Sanderson BE; Askew CD; Walker PJ; Green S; Stewart IB Clin Sci (Lond); 2006 Dec; 111(6):401-9. PubMed ID: 16928196 [TBL] [Abstract][Full Text] [Related]
37. Extracorporeal shock wave therapy improves the walking ability of patients with peripheral artery disease and intermittent claudication. Serizawa F; Ito K; Kawamura K; Tsuchida K; Hamada Y; Zukeran T; Shimizu T; Akamatsu D; Hashimoto M; Goto H; Watanabe T; Sato A; Shimokawa H; Satomi S Circ J; 2012; 76(6):1486-93. PubMed ID: 22447002 [TBL] [Abstract][Full Text] [Related]
38. The effect of supervised exercise therapy for intermittent claudication on lower limb lean mass. Vun SV; Miller MD; Delaney CL; Allan RB; Spark JI J Vasc Surg; 2016 Dec; 64(6):1763-1769. PubMed ID: 27633168 [TBL] [Abstract][Full Text] [Related]